Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow PAVmed Inc.

Get SEC filing alerts via email and in your feed for PAVmed Inc.

PAVM PAVMZ

PAVmed Inc.

About PAVmed Inc.

PAVmed Inc. is a multi-product life sciences company developing and commercializing innovative healthcare technologies. Its core segments include Lucid Diagnostics, offering non-invasive esophageal cancer screening tests, and Veris Health, providing digital cancer care platforms and remote monitoring solutions. The company targets large markets such as oncology and gastroenterology, leveraging proprietary diagnostics, digital health tools, and strategic partnerships to improve early detection, patient outcomes, and healthcare efficiency.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from PAVmed Inc.

1
1
PAVmed Inc. PAVmed Inc. Reports Revenue Growth to $22,000 but Incurred $8 Million Operating Loss in Q1 2026

Via official filing (AI summary) | 20 days ago | 0 comments

2
1
PAVmed Inc. PAVmed Inc. Reports Revenue Decline to $0.1 Million for Fiscal Year Ending December 31, 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
PAVmed Inc. PAVmed Reports Significant Revenue Decline and Increased Losses in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
PAVmed Inc. PAVmed Reports Significant Revenue Decline and Operating Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
PAVmed Inc. PAVmed Reports Revenue Decline and Net Income Turnaround in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
PAVmed Inc. PAVmed Reports 20% Revenue Growth to $3.0 Million Despite $33.6 Million Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
PAVmed Inc. PAVmed Reports Improved Financials, Net Income, and Reduced Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments